Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis

1 Jan 2008

Abstract excerpt

Ovarian cancer is the most lethal of all gynaecological cancers among women. Serum CA125 is the only biomarker that is used routinely and there is a need for further complementary biomarkers both in terms of sensitivity and specificity. N-glycosylation changes in ovarian cancer serum glycoproteins include a decrease in galactosylation of IgG and an increase in sialyl Lewis X (SLe(x)) on haptoglobin beta-chain,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Galectins and Cancer Biology
Share to Glycosylation and Glycoproteins Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19126966
DOI: 10.1155/2008/601583

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease PathogenesisPMID 19126966Read ↗

Evaluation of the serum <b> <i>N</i> </b> ‐linked glycome for the diagnosis of cancer and chronic inflammationSemantic proximity Read ↗

Clinical aspects of altered glycosylation of glycoproteins in cancerSemantic proximity Read ↗

Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian CancerSemantic proximity Read ↗

Protein glycosylation in cancers and its potential therapeutic applications in neuroblastomaSemantic proximity Read ↗

The Cancer-Associated Antigens Sialyl Lewisa/x and Sda: Two Opposite Faces of Terminal GlycosylationSemantic proximity Read ↗

Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer typesSemantic proximity Read ↗

Aberrant glycosylation of α3 integrins as diagnostic markers in epithelial ovarian cancerSemantic proximity Read ↗

Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospectsSemantic proximity Read ↗

Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeuticsSemantic proximity Read ↗

Characterization of disease‐associated <i> <scp>N</scp> </i> ‐linked glycoproteinsSemantic proximity Read ↗

Exploiting altered glycosylation patterns in cancer: Progress and challenges in diagnosis and therapySemantic proximity Read ↗

Serum immunoglobulin G N-glycome: a potential biomarker in endometrial cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.